WO2001003774A3 - Composition pharmaceutique de traitement de la calcification - Google Patents
Composition pharmaceutique de traitement de la calcification Download PDFInfo
- Publication number
- WO2001003774A3 WO2001003774A3 PCT/HU2000/000053 HU0000053W WO0103774A3 WO 2001003774 A3 WO2001003774 A3 WO 2001003774A3 HU 0000053 W HU0000053 W HU 0000053W WO 0103774 A3 WO0103774 A3 WO 0103774A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- calcification
- treatment
- pharmaceutical composition
- pharmaceutically acceptable
- Prior art date
Links
- 208000004434 Calcinosis Diseases 0.000 title abstract 2
- 230000002308 calcification Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 4
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 1
- 229960001138 acetylsalicylic acid Drugs 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000012752 auxiliary agent Substances 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 238000001802 infusion Methods 0.000 abstract 1
- 239000007972 injectable composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU54165/00A AU5416500A (en) | 1999-07-07 | 2000-06-02 | Pharmaceutical composition for the treatment of calcification |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9902296A HU9902296D0 (en) | 1999-07-07 | 1999-07-07 | Pharmaceutical composition for treating caltification |
HUP9902296 | 1999-07-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001003774A2 WO2001003774A2 (fr) | 2001-01-18 |
WO2001003774A3 true WO2001003774A3 (fr) | 2002-03-21 |
Family
ID=89998669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/HU2000/000053 WO2001003774A2 (fr) | 1999-07-07 | 2000-06-02 | Composition pharmaceutique de traitement de la calcification |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5416500A (fr) |
HU (1) | HU9902296D0 (fr) |
WO (1) | WO2001003774A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU227496B1 (en) * | 2001-11-16 | 2011-07-28 | Zoltan Dardai | Transdermal pharmaceutical composition containing aspirine for the treatment of sclerosis |
US20100099766A1 (en) * | 2008-10-16 | 2010-04-22 | Novartis Ag | Topical NSAID compositions having sensate component |
WO2011076401A1 (fr) | 2009-12-23 | 2011-06-30 | Holger Schankin | Compositions pharmaceutiques sensiblement exemptes d'eau, contenant de l'acide acétylsalicylique |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE596326A (fr) * | 1959-11-02 | 1961-02-15 | Guy Leopold Van Moorleghem | Soluté injectable d'aspirine et sou procédé de préparation |
GB1036314A (en) * | 1962-10-10 | 1966-07-20 | Ile De Rech S Phamaceutiques E | Injectable solution of acetylsalicylic acid |
FR2295753A1 (fr) * | 1974-12-23 | 1976-07-23 | Despin Jean | Composition a base d'acide acetyl-salicylique a usage topique |
FR2297612A1 (fr) * | 1975-01-20 | 1976-08-13 | Moorleghem Guy Van | Procede de fabrication d'un produit analgesique a usage externe |
JPS53124607A (en) * | 1977-04-06 | 1978-10-31 | Fujimoto Seiyaku Kk | Novel preparation of aspirin included in dextrine analogue |
US4275059A (en) * | 1977-03-28 | 1981-06-23 | The Procter & Gamble Company | Salicylate anti-inflammatory composition |
FR2556218A1 (fr) * | 1983-12-12 | 1985-06-14 | Gerard Alain | Produit pharmaceutique pour application locale constitue par l'association d'un principe actif medicamenteux-agent enzymatique |
US4533551A (en) * | 1984-02-17 | 1985-08-06 | American Home Products Corporation | Method of treating arthritis with etodolac |
JPS6416726A (en) * | 1987-07-08 | 1989-01-20 | Teisan Seiyaku Kk | Production of aspirin dl-lysine injection |
FR2648711A1 (fr) * | 1989-05-17 | 1990-12-28 | Jean Blum | Complexe soluble dans l'eau et stabilise de l'acide acetyl-salicylique et son procede de fabrication |
WO1996028168A1 (fr) * | 1993-04-22 | 1996-09-19 | The Hope Heart Institute | Methodes de traitement de la thrombose |
US5763425A (en) * | 1991-04-03 | 1998-06-09 | Gundersen Clinic, Ltd. | Suppression of thromboxane levels by percutaneous administration of aspirin |
WO2000002565A1 (fr) * | 1998-07-09 | 2000-01-20 | Alexander Galat | Composition d'acetylsalicylate de sodium injectable et procede afferent |
-
1999
- 1999-07-07 HU HU9902296A patent/HU9902296D0/hu unknown
-
2000
- 2000-06-02 AU AU54165/00A patent/AU5416500A/en not_active Abandoned
- 2000-06-02 WO PCT/HU2000/000053 patent/WO2001003774A2/fr active Application Filing
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE596326A (fr) * | 1959-11-02 | 1961-02-15 | Guy Leopold Van Moorleghem | Soluté injectable d'aspirine et sou procédé de préparation |
GB1036314A (en) * | 1962-10-10 | 1966-07-20 | Ile De Rech S Phamaceutiques E | Injectable solution of acetylsalicylic acid |
FR2295753A1 (fr) * | 1974-12-23 | 1976-07-23 | Despin Jean | Composition a base d'acide acetyl-salicylique a usage topique |
FR2297612A1 (fr) * | 1975-01-20 | 1976-08-13 | Moorleghem Guy Van | Procede de fabrication d'un produit analgesique a usage externe |
US4275059A (en) * | 1977-03-28 | 1981-06-23 | The Procter & Gamble Company | Salicylate anti-inflammatory composition |
JPS53124607A (en) * | 1977-04-06 | 1978-10-31 | Fujimoto Seiyaku Kk | Novel preparation of aspirin included in dextrine analogue |
FR2556218A1 (fr) * | 1983-12-12 | 1985-06-14 | Gerard Alain | Produit pharmaceutique pour application locale constitue par l'association d'un principe actif medicamenteux-agent enzymatique |
US4533551A (en) * | 1984-02-17 | 1985-08-06 | American Home Products Corporation | Method of treating arthritis with etodolac |
JPS6416726A (en) * | 1987-07-08 | 1989-01-20 | Teisan Seiyaku Kk | Production of aspirin dl-lysine injection |
FR2648711A1 (fr) * | 1989-05-17 | 1990-12-28 | Jean Blum | Complexe soluble dans l'eau et stabilise de l'acide acetyl-salicylique et son procede de fabrication |
US5763425A (en) * | 1991-04-03 | 1998-06-09 | Gundersen Clinic, Ltd. | Suppression of thromboxane levels by percutaneous administration of aspirin |
WO1996028168A1 (fr) * | 1993-04-22 | 1996-09-19 | The Hope Heart Institute | Methodes de traitement de la thrombose |
WO2000002565A1 (fr) * | 1998-07-09 | 2000-01-20 | Alexander Galat | Composition d'acetylsalicylate de sodium injectable et procede afferent |
Non-Patent Citations (7)
Title |
---|
BEKEMEIER H ET AL: "ON STEROID-SAVING DRUG COMBINATIONS IN CARRAGEENIN PAW EDEMA AND ADJUVANT ARTHRITIS", ARZNEIMITTEL FORSCHUNG. DRUG RESEARCH, EDITIO CANTOR. AULENDORF, DE, vol. 36, no. 10, 1986, pages 1521 - 1524, XP001015554, ISSN: 0004-4172 * |
DATABASE WPI Section Ch Week 197849, Derwent World Patents Index; Class B05, AN 1978-88532A, XP002176996 * |
DATABASE WPI Section Ch Week 198909, Derwent World Patents Index; Class B05, AN 1989-064967, XP002176997 * |
EULERT J ET AL: "HETROTOPE OSSIFIKATIONEN", UNFALLCHIRURGIE, URBAN UND VOGEL, MUNCHEN,, DE, vol. 100, no. 8, August 1997 (1997-08-01), pages 667 - 674, XP001014549, ISSN: 0340-2649 * |
KEITEL W: "KOMPLEXTHERAPIE IN DER RHEUMATOLOGIE", ZEITSCHRIFT FUER AERZTLICHE FORTBILDUNG, JENA, DD, vol. 85, no. 9, 1991, pages 410 - 415, XP001015395, ISSN: 0044-2178 * |
SAWAR A ET AL: "DRUG THERAPY OF RHEUMATOID ARTHRITIS", DRUGS OF TODAY / MEDICAMENTOS DE ACTUALIDAD, J.R. PROUS SS.A. INTERNATIONAL PUBLISHERS, ES, vol. 33, no. 5, June 1997 (1997-06-01), pages 299 - 306, XP001014547, ISSN: 0025-7656 * |
SOMOGYI A ET AL: "INHIBITION BY SALICYLATES OF VARIOUS CALCIFYING CONNECTIVE TISSUE REACTIONS", ARCHIVES INTERNATIONALES PHARMACODYNAMIE ET DE THERAPIE, NEW YORK, NY, US, vol. 177, no. 1, 1969, pages 211 - 223, XP001015523, ISSN: 0003-9780 * |
Also Published As
Publication number | Publication date |
---|---|
AU5416500A (en) | 2001-01-30 |
WO2001003774A2 (fr) | 2001-01-18 |
HU9902296D0 (en) | 1999-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001032596A8 (fr) | Composes d'acide carboxylique phenoxy et compositions utilisees afin de diffuser des agents actifs | |
CA2411754A1 (fr) | Acide 4-¬(4-chloro-2-hydroxybenzoyl)amino|butanoique et compositions d'administration d'agents actifs | |
CA2370565A1 (fr) | Compositions pharmaceutiques contenant de la vitamine d pour application cutanee | |
WO2001090091A8 (fr) | Inhibiteurs de 11-beta-hydroxy-steroide-deshydrogenase de type 1 | |
CA2258920A1 (fr) | Acide hyaluronique autoreticule et compositions pharmaceutiques associees pour le traitement des arthropathies | |
AU2002214953A1 (en) | Pharmaceutical composition for the systematic administration of pharmacologically active ingredients containing polyol fatty acid esters | |
IE940583L (en) | Topical antimicrobial pharmaceutical compositions | |
MXPA04004837A (es) | Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1. | |
MXPA04004842A (es) | Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1. | |
IL161154A0 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
NZ524138A (en) | Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents | |
AU2001278696A1 (en) | Aqueous pharmaceutical compositions | |
WO2002019969A3 (fr) | Acide (5-(2-hydroxy-4-chlorobenzoyl) aminovalerique et ses sels, compositions contenant l'acide et ses sels pour acheminer des agents actifs | |
CA2360220A1 (fr) | Composes a base d'oxadiazole et compositions destinees a l'apport d'agents actifs | |
CA2284774A1 (fr) | Compositions antitussives a base de theobromine | |
WO2002015959A3 (fr) | Composes et compositions permettant de distribuer des agents actifs | |
RS44204A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
IL155788A (en) | A highly purified ifn – β active and mannitol-containing preparation, a method to make an improved stability of ifn – β active, and a method to enhance the stability of ifn – β in biologically active formulation. | |
WO2001085139A3 (fr) | Vecteur d'administration semi-solide et compositions pharmaceutiques associees | |
WO1996001634B1 (fr) | Compositions a base d'oxytretracycline a action prolongee | |
WO2001003774A3 (fr) | Composition pharmaceutique de traitement de la calcification | |
WO2002100338A3 (fr) | Compose et composition permettant d'administrer des principes actifs | |
GEP20032970B (en) | Pharmaceutical Compositions of Tizoxanide and Nitazoxanide | |
WO2002000208A3 (fr) | Preparations de derives d'acide 3-n-formylhydroxylaminopropylphosphonique ou de derives d'acide 3-n-acetylhydroxylaminopropylphosphonique combines avec des principes actifs pharmaceutiques speciaux | |
EA200200415A1 (ru) | Композиция фармацевтического носителя |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |